MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients - Contacts and Locations

Home

MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients

This study has been completed.

Study NCT00082537. Last updated on May 13, 2008. Information provided by Merck

Please refer to this study by its ClinicalTrials.gov identifier: NCT00082537

Sponsors and Collaborators

Merck

Investigators


Study Director:	Medical Monitor	Merck